Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use Of Weekly Topotecan As Second Line Therapy In Small Cell Lung Cancer

NCT00087048 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT00087048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00087048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use Of Weekly Topotecan As Second Line Therapy In Small Cell Lung Cancer
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2004
Completion date
February 28, 2006
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer